…ent, and outcomes of hypothyroidism in PC patients treated with apalutamide.Material and Methods This retrospective observational study inc…
Apalutamide
This drug is selected. Its supporting articles are shown below.
Articles mentioning Apalutamide
7 articles · page 1 of 1…s vs one 240 mg tablet once daily) could influence adherence to apalutamide treatment in patients with metastatic hormone-sensitive prostat…
…progression, persistence, or recurrence and were candidates for piflufolastat PET per Central Pharmacy and Therapeutics Commission protocol. …
…eceived abiraterone, 31% apalutamide, 26% enzalutamide, and 11% docetaxel. Median PFS and OS were 32 and 50 months, respectively, in the …
…metastatic hormone-sensitive prostate cancer (mHSPC) (ARASENS). Darolutamide was commercialised in 2020.Aim and Objectives To evaluate the t…
…Results Of 88 patients (mean age 76.9 ± 8.2 years), 70 received abiraterone, 8 apalutamide, six enzalutamide, three darolutamide, and one o…
… 5% had ovarian, renal or lung cancer. The involved drugs were: enzalutamide(25), apalutamide(14), abiraterone (9), abemaciclib(6), capecita…